Helsinn is a global pharmaceutical company.
We provide products that improve the lives of patients with cancer and chronic diseases.
We have a comprehensive technical organization.
Helsinn operates a unique integrated licensing business model, achieving success with over 30 partners worldwide in more than 140 countries to enable the commercialization of innovative products in supportive care.
For 50 years we have achieved success with our partners, who share our values and ambition to improve the everyday lives of patients.
Helsinn operates a unique integrated licensing business model, achieving success with over 30 partners worldwide in more than 140 countries.
You are about to enter a website not intended for a US audience.Please confirm your acceptance to continue
You are about to enter a website only intended for a US audience. Please confirm your acceptance to continue.
Please click ‘Continue to external site’ if you want to continue.